Surgery in locally advanced BC and metastatic in LMICs.

Rita SAKR
Surgeon, Dubai, EUA

Radiotherapy schedules to solve the lack of tools in LMICs.

Yazid BELKACEMI
Radiotherapist, Créteil, France

New drugs and options in MBC: Are there drugs that must be offered to patients in 2023?

Joseph GLIGOROV
Oncologist, Paris, France

Economics issues and breast cancer

Jean Jacques ZAMBROWSKI
Economist, Paris, France

Radiotherapy options.

Yazid BELKACEMI
Radiotherapist, Créteil, France

Molecular profiling of breast cancers.

Benjamin VERRET
Oncologist, Villejuif, France

Preoperative assessment with FDG Pet CT scan.

Celia MAHMOUDI
Nuclear Medicine, Tizi Ouzou, Algeria

Multidisciplinary surgery planning of triple negative metastatic breast cancers.

Didier BOURGEOIS
Surgeon, Neuilly Sur Seine, France

Innovative Strategies in Breast Cancer: AI Insights and Global Health Equity

At the line-up you’ll find our speakers with exclusives interviews and their full presentation for registered members. Stay tuned, more content and functionalities are coming on the website. Thank you for your interest and fidelity.
READ ARTICLE

Breast cancer dynamics: Molecular signature, Radiotherapy and Nuclear Medicine

At the line-up you’ll find our speakers with exclusives interviews and their full presentation for registered members. Stay tuned, more content and functionalities are coming on the website. Thank you for your interest and fidelity.
READ ARTICLE

Screening program: now and beyond

At the line-up you’ll find our speakers with exclusives interviews and their full presentation for registered members. Stay tuned, more content and functionalities are coming on the website. Thank you for your interest and fidelity.
READ ARTICLE

Unraveling the Challenges of Metastasis: Comprehensive Localized Treatment Strategies

Navigating the complexities of metastasis in breast cancer demands a specialized and multifaceted approach. As cancer cells traverse the bloodstream or lymphatic system to distant organs or tissues, addressing this challenge requires a multidisciplinary understanding. In this focused exploration, our experts illuminate key areas concerning bone, liver, thoracic, and brain metastases, shedding light on the intricacies of localized treatments. Spotlight on Spine Metastasis Bone metastasis stands as the predominant type in metastatic breast cancer, constituting approximately 80% of cases. Nicolas AMORETTI, interventional Radiologist, Nice, France will discuss the interest of mini invasive procedures such as percutaneous vertebroplasty and the exiting…
READ ARTICLE